πŸ‡ΊπŸ‡Έ FDA
Patent

US 8183373

Solid state forms of sitagliptin salts

granted A61PA61P3/10

Quick answer

US patent 8183373 (Solid state forms of sitagliptin salts) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P3/10